放射性化合物
伯森在台獨家代理國際知名品牌 Revvity 與 Moravek Biochemicals 之放射性產品，品項豐富齊全。其中由 Revvity 所出品的 NEN® 放射性產品已具有超過 50 年以上的生產製造經驗，品質有口皆碑！各種常用品項已為您整理分類於下表中，若您無法找尋到需要的產品，歡迎與我們聯繫，我們將協助您快速取得適用產品資訊。
放射性標定核苷酸
32P-Labeled Nucelotides
| Product | Specific Acticity [Ci/mmol] |
Concentration [mCi/ml] |
Concentration [μM] |
Cat. No. EasyTide, ready to use Shipped ambient, store at 2~8℃ |
Cat. No. Shipped in dry ice, stored at -20℃ |
|---|---|---|---|---|---|
| ATP, [α-32P]- | 800 3000 |
10 10 |
12.5 3.3 |
— PK-BLU503H |
PK-BLU003X PK-BLU003H |
| CTP, [α-32P]- | 800 3000 |
10 10 |
12.5 3.3 |
PK-BLU508X PK-BLU508H |
PK-BLU008X PK-BLU008H |
| GTP, [α-32P]- | 800 3000 |
10 10 |
12.5 3.3 |
— PK-BLU506H |
PK-BLU006X PK-BLU006H |
| UTP, [α-32P]- | 800 800 800 3000 6000 |
10 20 40 10 40 |
12.5 25 50 3.3 6.7 |
PK-BLU507X PK-BLU507T PK-BLU507C PK-BLU507H PK-BLU507Z |
PK-BLU007X — PK-BLU007C PK-BLU007H PK-BLU007Z |
| dATP, [α-32P]- | 800 3000 6000 |
10 10 20 |
12.5 3.3 3.3 |
PK-BLU512A PK-BLU512H PK-BLU512Z |
— PK-BLU012H PK-BLU012Z |
| dCTP, [α-32P]- | 800 3000 6000 |
10 10 20 |
12.5 3.3 3.3 |
PK-BLU513A PK-BLU513H PK-BLU513Z |
PK-BLU013A PK-BLU013H PK-BLU013Z |
| dGTP, [α-32P]- | 3000 6000 |
10 20 |
3.3 3.3 |
PK-BLU514H PK-BLU514Z |
— PK-BLU014Z |
| dTTP, [α-32P]- | 800 3000 |
10 10 |
12.5 3.3 |
PK-BLU505A PK-BLU505H |
PK-BLU005A PK-BLU005H |
| 3’dATP, [α-32P]- | 5000 | 10 | 2 | — | PK-BLU026 |
| ATP, [γ-32P]- | 10 3000 3000 6000 |
2 5 10 10 |
200 1.7 3.3 1.7 |
— PK-BLU502H PK-BLU502A PK-BLU502Z |
PK-BLU002 PK-BLU002H PK-BLU002A PK-BLU002Z |
| GTP, [γ-32P]- | 6000 | 10 | 1.7 | PK-BLU504Z | PK-BLU004Z |
| NAD, [32P]- | 800 | 5 | 6.3 | — | PK-BLU023X |
| pCp, [5’-32P]- | 3000 | 10 | 3.3 | — | PK-BLU019A |
33P-Labeled Nucelotides
| Product | Specific Acticity [Ci/mmol] |
Concentration [mCi/ml] |
Concentration [μM] |
Cat. No. EasyTide, ready to use Shipped ambient, store at 2~8℃ |
Cat. No. Shipped in dry ice, stored at -20℃ |
|---|---|---|---|---|---|
| ATP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG603H | — |
| CTP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG608H | — |
| GTP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG606H | — |
| UTP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG607H | PK-NEG307H |
| dATP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG612H | PK-NEG312H |
| dCTP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG613H | PK-NEG313H |
| dTTP, [α-33P]- | 3000 | 10 | 3.3 | PK-NEG605H | — |
| ATP, [γ-33P]- | 3000 3000 |
10 10 |
3.3 3.3 |
PK-NEG602H PK-NEG602K |
PK-NEG302H — |
| GTP, [γ-33P]- | 3000 | 10 | 3.3 | PK-NEG604H | — |
| 2-Methylthio ADP, [β-33P] | 3000 | 2 | 3.3 | — | PK-NEG380H |
35S-Labeled Nucelotides
| Product | Specific Acticity [Ci/mmol] |
Concentration [mCi/ml] |
Concentration [μM] |
Cat. No. EasyTide, ready to use Shipped ambient, store at 2~8℃ |
Cat. No. Shipped in dry ice, stored at -20℃ |
|---|---|---|---|---|---|
| ATPαS, [35S]- | 1250 | 12.5 | 10 | — | PK-NEG033H |
| CTPαS, [35S]- | 1250 1250 |
12.5 70 |
10 56 |
— — |
PK-NEG064H PK-NEG064C |
| UTPαS, [35S]- | 800 1250 |
40 12.5 |
50 10 |
— PK-NEG739H |
PK-NEG039C PK-NEG039H |
| dATPαS, [35S]- | 500 1250 |
10 12.5 |
20 10 |
— PK-NEG734H |
PK-NEG034S PK-NEG034H |
| ATPγS, [35S]- | 25–100 1250 |
12.5 12.5 |
125–500 10 |
— — |
PK-NEG027 PK-NEG027H |
| GTPγS, [35S]- | 1250 1250 |
12.5 12.5 |
10 10 |
— — |
PK-NEG030H PK-NEG030X |
| PAPS 3’, [35S]- | 1–3 | 0.5 | 167–500 | — | PK-NEG010 |
35S 標定胺基酸
| Product | Specific Activity [Ci/mmol] |
Activity Concentration [mCi/ml] |
Cat. No. |
|---|---|---|---|
| Cysteine, L-[35S]- Packaged in 10 mM DTT. |
>1000 | 11 | PK-NEG022T |
| EXPRE35S35S Protein Labeling Mix, [35S]-, (EasyTag™) A mixture of approximately 73% [35S]-methionine and 22% L-[35S]-cysteine prepared directly from the hydrolysate of E. coli grown in the presence of carrier-free 35SO4 with added stabilizer. Packaged in a stabilized aqueous solution. |
>1000 | 11 | PK-NEG772 |
| EXPRE35S35S Protein Labeling Mix, [35S]- A mixture of approximately 73% [35S]-methionine and 22% L-[35S]-cysteine prepared directly from the hydrolysate of E. coli grown in the presence of carrier-free 35SO4. Packaged in 50 mM tricine (pH 7.4) and 10 mM 2-mercaptoethanol. |
>1000 | 11 | PK-NEG072 |
| Methionine, L-[35S]- Cell Labeling Grade Packaged in 10 mM 2-mercaptoethanol. |
>600 | 31.5 | PK-NEG009L |
| Methionine, L-[35S]- Packaged in 10 mM 2-mercaptoethanol. |
>800 | 11 | PK-NEG009H |
| Methionine, L-[35S]-, (EasyTag) Packaged in a stabilized aqueous solution with blue dye. |
>1000 | 10.2 | PK-NEG709A |
| Methionine, L-[35S]- Packaged in 50 mM tricine (pH 7.4) and 10 mM 2-mercaptoethanol. |
>1000 | 10.2 | PK-NEG009A |
| Methionine, L-[35S]- Packaged in 10 mM 2-mercaptoethanol. |
>1000 | 11 | PK-NEG009T |
| Methionine, L-[35S]- Packaged in 50 mM tricine (pH 7.4) and 10 mM 2-mercaptoethanol. |
>1000 | 43.3 | PK-NEG009C |
125I 標定產物
| Product | Cat. No. |
|---|---|
| A-85380, [125I]- | PK-NEX413 |
| AB-MECA, [125I]-, (4-amino-3-[125I]iodobenzyl-5’-N-) | PK-NEX312 |
| ACTH, (1-39) Tyr2-[125I]- | PK-NEX342 |
| ACTH, (1-39) Tyr23-[125I]- | PK-NEX165 |
| Adenosine 3’,5’-cyclic phosphoric acid, 2’-O-succinyl [125I]-iodotyrosine methyl ester | PK-NEX130 |
| Adrenomedullin, [125I]Tyr-, (human, 13–52) | PK-NEX385 |
| Adrenomedullin (Rat), [125I]- | PK-NEX427 |
| AGRP (Ac-87-132), [125I]-, (human, synthetic) | PK-NEX372 |
| Albumin, Bovine Serum, [125I]-, ([125I]-BSA) | PK-NEX076 |
| Aminopotentidine, [125I] | PK-NEX431 |
| Amylin, [125I]-, (rat) | PK-NEX448 |
| Angiotensin I (Tyr4), [125I]-, (human) | PK-NEX101 |
| Angiotensin II (Sar1,Tyr4, Ile8), [125I]- | PK-NEX248 |
| Angiotensin II (Tyr4), [125I]-, (human) | PK-NEX105 |
| Angiotensin IV (Tyr2), [125I]-, (human) | PK-NEX295 |
| Anti-mouse IgG, whole antibody, [125I]-, (goat) | PK-NEX159 |
| Anti-rabbit IgG, whole antibody, [125I]-, (goat) | PK-NEX155 |
| Antisauvagine-30 (8-1-His2), [(125I)]- | PK-NEX399 |
| Apamin (His18-NH2), [125I]- | PK-NEX242 |
| Apelin 13 (Glp65, Nle75, Tyr7), [125I]- | PK-NEX393 |
| Atrial Natriuretic Factor - Tyr28 (rat) - [125I]-ANF | PK-NEX228 |
| α- Atrial Natriuretic Peptide - Tyr28 (human) [125I] α-ANP | PK-NEX425 |
| BeKm-1 (Tyr11), [125I]- | PK-NEX412 |
| Bolton-Hunter Reagent, [125I]-, (monoiodinated) | PK-NEX120 |
| Bolton-Hunter Reagent, [125I]-, (diiodinated) | PK-NEX120H |
| Bombesin (D-Tyr6 , βAla11, Phe13, Nle14), [125I]-, (6–14) | PK-NEX377 |
| Bombesin (Tyr4), [125I]- | PK-NEX258 |
| α-Bungarotoxin (Tyr54), [125I]- | PK-NEX126 PK-NEX126H |
| Calcitonin Gene-Related Peptide, [125I]-, ([125I]-hCGRP), (human) | PK-NEX354 |
| Calcitonin [Tyr12] (Human), [125I] | PK-NEX422 |
| Calcitonin Gene-Related Peptide,- 2-[125I]-iodohistidyl10,(human) Receptor Grade | PK-NEX442 |
| Calcitonin[Tyr22] (Salmon), [125I] | PK-NEX423 |
| CCL15, [125I]-, (human, recombinant) | PK-NEX401 |
| CGP 42112A, [125I]- | PK-NEX324 |
| Cholecystokinin Octapeptide, [125I]-, Bolton-Hunter labeled, ([125I]-CCK-8) | PK-NEX203 |
| Chorionic Gonadotropin [125I], ([125I]-hCG), (human) | PK-NEX106 |
| 6-Ckine, [125I]-, Bolton-Hunter labeled, (CCL21), (human, recombinant) | PK-NEX387 |
| Complement C3a, [125I]-, Bolton-Hunter labeled, (human) | PK-NEX356 |
| Complement C5a, [125I]-, Bolton-Hunter labeled, (human, recombinant) | PK-NEX250 |
| ω-Conotoxin GVIA (Tyr22), [125I]- | PK-NEX239 |
| ω-Conotoxin MVIIC, [125I]- | PK-NEX323 |
| Corticotropin Releasing Factor (Tyr0), [125I]-, (ovine) | PK-NEX217 |
| Corticotropin Releasing Factor (Tyr0), [125I]-, (human, rat) | PK-NEX216 |
| Cortisol-3-(0-carboxymethyl)oximino-(2-[125I], iodohistamine) | PK-NEX435 |
| CTACK, [125I]-, (CCL27), (human, recombinant) | PK-NEX391 |
| CXCL16, [125I]-, (human, recombinant) | PK-NEX398 |
| (-)-Cyanopindolol, [125I]iodo- | PK-NEX189 |
| (±)-Cyanopindolol, [125I]iodo- | PK-NEX174 |
| Dendrotoxin-a-[125I] | PK-NEX434 |
| 2’-Deoxycytidine-5’-triphosphate, tetraammonium salt, 5-[125I]iodo- | PK-NEX074 |
| (±)-DOI, [125I]- | PK-NEX255 |
| Echistatin [125I] - | PK-NEX439 |
| Eledoisin (Lys4), [125I]-, Bolton-Hunter labeled | PK-NEX218 |
| Endothelin-1 (Tyr13), [125I]-, ([125I]-ET-1), (human, porcine) | PK-NEX259 |
| Eotaxin, [125I]-, (human, recombinant) | PK-NEX314 |
| Epibatidine, [125I]-, ([125I]-IPH) | PK-NEX358 |
| Epidermal Growth Factor, [125I]- (human, recombinant) | PK-NEX428 |
| Epidermal Growth Factor, [125I]-, ([125I]-EGF), (murine) | PK-NEX160 |
| Estradiol-6-(0-carboxymethyl)oximino-(2-[125I], iodohistamine) | PK-NEX438 |
| 3,17β-Estradiol, 16a-[125I]iodo- | PK-NEX144 PK-NEX144L |
| Exendin, [125I]-, (9–39) | PK-NEX335 |
| Fibrinogen (Human), [125I] | PK-NEX430 |
| Fibroblast Growth Factor Basic, [125I]-, ([125I]-FGF basic), (human, recombinant) | PK-NEX268 |
| Follicle Stimulating Hormone, [125I]-, ([125I]-FSH) | PK-NEX173 |
| Fractalkine, [125I]-, (human, recombinant) | PK-NEX368 |
| Galanin, [125I]-, (2–11) | PK-NEX416 |
| Galanin, [125I]-, (human) | PK-NEX333 |
| Galanin, [125I]-, (porcine) | PK-NEX243 |
| Gastric Inhibitory Polypeptide, [125I]-, (human) | PK-NEX402 |
| Gastrin Releasing Peptide (porcine), [125I-Tyr15]-[125I]-GRP(p) | PK-NEX421 |
| Gastrin I (Tyr12), [125I]-, (human) | PK-NEX176 |
| Ghrelin (His), [125I]-, (human) | PK-NEX388 |
| Glucagon-like Peptide-1, [125I]-, ([125I]-GLP-1), (7–36) | PK-NEX308 |
| Glucagon-like Peptide-2, [125I]-, ([125I]-GLP-2) | PK-NEX390 |
| Glucagon, [125I]-, receptor grade | PK-NEX207 |
| Granulocyte Macrophage-Colony Stimulating Factor, [125I]-, | PK-NEX249 |
| GRO Alpha/MGSA, [125I]- | PK-NEX321 |
| Growth Hormone, [125I]-, ([125I]-hGH), (human) | PK-NEX100 |
| Guanosine 3’,5’-cyclic phosphoric acid, 2’-O-succinyl, [125I]-iodotyrosine, methyl ester | PK-NEX131 |
| HEAT, [125I]- | PK-NEX182 |
| Hemokinin-1, [125I]-, Bolton-Hunter labeled | PK-NEX414 |
| I309, [125I]-, Bolton-Hunter labeled, (human, recombinant) | PK-NEX364 |
| INSL-3, [125I]- | PK-NEX419 |
| Insulin, [125I]-(human, recombinant) | PK-NEX420 |
| Insulin, [125I]-, (porcine) | PK-NEX104 |
| Insulin, (TyrA14), [125I]-, receptor grade, (porcine) | PK-NEX196 |
| Insulin-like Growth Factor-I, [125I]-, ([125I]-IGF-I), (human, recombinant) | PK-NEX241 |
| Insulin-like Growth Factor ll (human, recombinant), [125I] | PK-NEX429 |
| Interleukin-1β, [125I]-, ([125I]-IL-1β), (human, recombinant) | PK-NEX232 |
| Interleukin-2, [125I]-, ([125I]-IL-2), (human, recombinant) | PK-NEX229 |
| Interleukin-6, [125I]-, ([125I]-IL-6), (human, recombinant) | PK-NEX269 |
| Interleukin-8, [125I]-, ([125I]-IL-8), (human, recombinant) | PK-NEX277 |
| Interleukin-8 (IL-8), [125I]-, (human, recombinant) receptor grade | PK-NEX443 |
| Iodoclonidine, p-[125I]-, (2-(2,6-dichloro-4)-[125I]-) | PK-NEX253 |
| Iododeoxyuridine, 5-[125I]- | PK-NEX072 |
| Iodoproxyfan-[125I] | PK-NEX436 |
| Iodosulpride-[125I], (dopamine D2 antagonist) | PK-NEX441 |
| IP-10, [125I]-, Bolton-Hunter labeled, (human, recombinant) | PK-NEX348 |
| I-TAC, [125I]-, (human, recombinant) | PK-NEX376 |
| JE, [125I]-, Bolton-Hunter labeled, (MCP-1, murine, recombinant) | PK-NEX313 |
| Leptin, [125I]-, (human, recombinant) | PK-NEX347 |
| Leptin, [125I]-, (murine, recombinant) | PK-NEX340 |
| Luteinizing Hormone Releasing Hormone (D-Trp6), [125I]-, ([125I]-LH-RH) | PK-NEX365 |
| Luteinizing Hormone Releasing Hormone (Tyr5), [125I]-, ([125I]-LH-RH) | PK-NEX163 |
| (+)-Lysergic Acid Diethylamide, 2-[125I]iodo-, ([125I]-LSD) | PK-NEX199 |
| Mamba Intestinal Toxin-1, [125I]-Bolton-Hunter labeled [125I]-MIT-1 | PK-NEX414 |
| Melanin Melanin Concentrating Hormone (Phe13, Tyr19), [125I]-, (Phe13[125I]Tyr19-MCH), (human, mouse, rat) | PK-NEX375 |
| Melanin Concentrating Hormone, [125I]-, ([125I]-MCH), (human) | PK-NEX373 |
| Melanin Concentrating Hormone-1 Receptor antagonist, [125I]-, ([125I]-hMCH-1R), (human) | PK-NEX406 |
| Melatonin, 2-[125I]iodo- | PK-NEX236 |
| Metastin, [125I]-, (45–54) | PK-NEX395 |
| Monocyte Chemoattractant Protein-1 [125I], Bolton-Hunter labeled, ([125I]-MCP-1), (human, recombinant) | PK-NEX332 |
| MIP-1α, [125I]-, (human, recombinant) | PK-NEX298 |
| MIP-1β (Leu3, Gly47), [125I]-, (human, recombinant) | PK-NEX299 |
| MIP-3α, [125I]-, (human, recombinant) | PK-NEX371 |
| MIP-3β, [125I]-, (human, recombinant) | PK-NEX370 |
| MIT-1, [125I]-, Bolton-Hunter labeled | PK-NEX410 |
| Motilin, [125I]- | PK-NEX378 |
| α-MSH (Nle4, D-Phe7), [125I]- | PK-NEX352 |
| MT II (His), [125I]- | PK-NEX374 |
| β-Nerve Growth Factor, [125I]-, (human, recombinant) | PK-NEX440 |
| Neurokinin A, [125I]-, ([125I]-Substance K, [125I]-NKA) | PK-NEX252 |
| Neurokinin B (MePhe7) His, [125I]-, ([125I]-NKB) | PK-NEX285 |
| Neuromedin U-25 (Tyr18), [125I]-, ([125I]-NMU-25), (porcine) | PK-NEX383 |
| Neuromedin U-8, [125I]-, ([125I]-NMU-8) | PK-NEX392 |
| Neuropeptide B23 (Des-Br), [125I]-, ([125I]-NPB23), (human) | PK-NEX405 |
| Neuropeptide FF (D-Tyr1, N-MePhe3), [125I]-, ([125I]-NPFF) | PK-NEX381 |
| Neuropeptide S (Tyr10), [125I]-, ([125I]-NPS), (human) | PK-NEX411 |
| Neuropeptide W23, [125I]-, ([125I]-NPW23), (human) | PK-NEX403 |
| Neuropeptide Y (Lys4), [125I]-Bolton Hunter labeled, [125I]-NPY, (porcine) | PK-NEX222 |
| Neurotensin (Tyr3), [125I]- | PK-NEX198 |
| Nociceptin (Tyr14), [125I]- | PK-NEX338 |
| Orexin A, [125I]- | PK-NEX367 |
| Ornithine Vasotocin Analog, [125I]-, ([125I]-OVTA) | PK-NEX254 |
| Oxytocin (Tyr2), [125I]- | PK-NEX187 |
| PACAP 27, [125I]- | PK-NEX294 |
| PDGF-BB (h,r), [125I] | PK-NEX433 |
| Pancreatic Polypeptide, [125I]-, (human) | PK-NEX315 |
| Parathyroid Hormone (Nle8,18, Tyr34), [125I]-, ([125I]-PTH), (human, 1–34) | PK-NEX397 |
| Parathyroid Hormone amide (Nle8,21, Tyr34), [125I]-, ([125I]-PTH amide), (rat, 1–34) | PK-NEX353 |
| Peptide YY (Leu31, Pro34), [125I]-, ([125I]-PYY), (porcine) | PK-NEX334 |
| Peptide YY, [125I]-, ([125I]-PYY), (human) | PK-NEX341 |
| Peptide YY, [125I]-, ([125I]-PYY), (porcine) | PK-NEX240 |
| (-)-Pindolol, [125I]iodo- | PK-NEX211 |
| R (+) trans-7-hydroxy-PIPAT, [125I]- | PK-NEX307 |
| Prazosin Analog, [125I]iodoazido-, (Iodoarylazidoprazosin) | PK-NEX219 |
| Prolactin, [125I]-, (rat) | PK-NEX108 |
| Protein A, [125I]-, (human, recombinant) | PK-NEX146 PK-NEX146L |
| Protein G, [125I]-, Bolton-Hunter labeled, (human, recombinant) | PK-NEX237 |
| ProTx-II, [125I]-, (tarantula) | PK-NEX450 |
| QRFP-43, [125I]-, (human) | PK-NEX408 |
| RANTES, [125I]-, (human, recombinant) | PK-NEX292 |
| H2 Relaxin, [125I]-, Bolton-Hunter labeled | PK-NEX409 |
| H3 Relaxin, [125I]- | PK-NEX418 |
| Resiniferatoxin, [125I]- | PK-NEX394 |
| RTI-121, [125I]- | PK-NEX318 |
| RTI-55, [125I]- | PK-NEX272 |
| S36057 (Tyr), [125I]- | PK-NEX396 |
| SB258585, [125I] | PK-NEX424 |
| Sauvagine (Tyr0), [125I]- | PK-NEX306 |
| SDF-1α, [125I]-, (human, recombinant) | PK-NEX346 |
| SHU9119, [125I]- | PK-NEX362 |
| Somatostatin-14 (Tyr11), [125I]- | PK-NEX389 |
| Somatostatin-14 (Tyr11), [125I]-, (human, recombinant) receptor grade | PK-NEX446 |
| Somatostatin-28, [125I] | PK-NEX447 |
| 2’-Spiperone, [125I]iodo- | PK-NEX284 |
| Streptavidin, [125I]- | PK-NEX238 |
| Substance P (Lys3), [125I]-, Bolton-Hunter labeled | PK-NEX190 |
| Substance P (Tyr8), [125I]- | PK-NEX152 |
| TARC, [125I]-, (human, recombinant) | PK-NEX369 |
| Thyrotropin Releasing Hormone (His2), [125I]-, ([125I]-TRH) | PK-NEX153 |
| Thyroxine, L-, [125I]-, ([125I]-T4) | PK-NEX111 |
| Transferrin, [125I]-, diferric, (human) | PK-NEX212 |
| Transforming Growth Factor β-1, [125I]-, ([125I]-TGF-β1), (human, recombinant) | PK-NEX267 |
| Triiodothyronine, L-3,3’,5’-[125I]-, ([125I]-Reverse T3) | PK-NEX109 |
| Triiodothyronine, L-3,5,3’-[125I]-, ([125I]-T3) | PK-NEX110 PK-NEX110H PK-NEX110X |
| Tumor Necrosis Factor-α, [125I]-, ([125I]-rTNFα), (human, recombinant) | PK-NEX257 |
| Ubiquitin, [125I]- | PK-NEX404 |
| Urotensin II (Tyr9), [125I]-, (human) | PK-NEX379 |
| Vascular Endothelial Growth Factor, [125I]-, ([125I]-VEGF), (human, recombinant) | PK-NEX328 |
| Vasoactive Intestinal Polypeptide, [125I]-, ([125I]-VIP), (human, porcine, rat) | PK-NEX192 |
| Vasopressin (linear), V1A antagonist (phenylacetyl1, 0-Me-D-Tyr2, Arg6,8, Tyr9), [125I]- | PK-NEX310 |
| Vasopressin (Tyr2, Arg8), [125I]- | PK-NEX128 |
| WKYMVm, [125I]-, Bolton-Hunter labeled | PK-NEX386 |
3H 標定產物
3H-Labeled Amino Acids
| Product | Molecular Formula & Labeling Position(s) | Specific Acticity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
|---|---|---|---|---|
| Alanine, L-[3-3H]- | CH3CH(NH2)CO2H | 65–85 | 1 | PK-NET348 |
| Arginine monohydrochloride, L-[2,3,4-3H]- | H2NC(NH)NH(CH2)3CH(NH2)CO2H.HCl | 40–70 | 1 | PK-NET1123 |
| Aspartic acid, D-[2,3-3H]- | HO2CCH2CH(NH2)CO2H | 10–25 | 1 | PK-NET581 |
| Glutamic acid, L-[3,4-3H]- | HO2C(CH2)2CH(NH2)CO2H | 40–80 | 1 | PK-NET490 |
| Glutamine, L-[3,4-3H(N)]- | H2NCO(CH2)2CHCNH2CO2H | 30–60 | 1 | PK-NET551 |
| Glycine, [2-3H]- | H2NCH2CO2H | 30–60 | 1 | PK-NET004 |
| Leucine, L-[3,4,5-3H(N)]- | (CH3)2CHCH2CH(NH2)CO2H | 100–150 | 1 | PK-NET460 |
| Leucine, L-[3,4,5-3H(N)]- | (CH3)2CHCH2CH(NH2)CO2H | 100–150 | 5 | PK-NET460A |
| Leucine, L-[4,5-3H(N)]- | (CH3)2CHCH2CH(NH2)CO2H | 40–60 | 1 | PK-NET135H |
| Lysine, L-[4,5-3H(N)]- | H2NCH2CH2CH2CH2CH(NH2)CO2H.HCl | 80–110 | 1 | PK-NET376 |
| Methionine, L-[methyl-3H]- | CH3S(CH2)2CH(NH2)CO2H | 70–85 | 1 | PK-NET061X |
| Proline, L-[2,3-3H]- | HNCH2CH2CH2CHCO2H | 25–55 | 1 | PK-NET323 |
| Proline, L-[2,3,4,5-3H]- | HNCH2CH2CH2CHCO2H | >75 | 1 | PK-NET483 |
| Proline, L-[2,3,4,5-3H]- | HNCH2CH2CH2CHCO2H | 85-130 | 5 | PK-NET483V |
| Serine, L-[3H(G)]- | HOCH2CH(NH2)CO2H | 15–40 | 1 | PK-NET248 |
| Tyrosine, L-[ring-3,5-3H]- | p-HOC6H4CH2CH(NH2)CO2H | 40–60 | 1 | PK-NET127 |
3H-Labeled Thymidines
| Application | Product | Specific Acticity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
|---|---|---|---|---|
| To study DNA proliferation rates | Thymidine, [methyl-3H]- Steri-packaged in an aqueous solution. Not for human use. |
2 | 1 | PK-NET027A |
| Thymidine, [methyl-3H]- Steri-packaged in an aqueous solution. Not for human use. |
6.7 | 1 | PK-NET027 | |
| Thymidine, [methyl-3H]- Packaged in ethanol:water (7:3). Not for human use |
20 | 1 | PK-NET027E | |
| Thymidine, [methyl-3H]- Steri-packaged in ethanol:water (2:98). Not for human use |
23–27 | 1 | PK-NET027L | |
| Thymidine, [methyl-3H]- Steri-packaged in ethanol:water (2:98). Not for human use |
40–60 | 1 | PK-NET027W | |
| Thymidine, [methyl-3H]- Steri-packaged in an aqueous solution. Not for human use. |
20 | 1 | PK-NET027X | |
| Thymidine, [methyl-3H]- Steri-packaged in an aqueous solution. Not for human use. |
70–90 | 1 | PK-NET027Z | |
| To study total nucleic acid proliferation rates | Thymidine, [6-3H]- Steri-packaged in an aqueous solution. Not for human use. |
>10 | 1 | PK-NET355 |
| For DNA probe labeling | Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl-3H]-, Packaged in ethanol:water (1:1). |
10–25 | 1 | PK-NET221H |
| Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl-3H]- Packaged in ethanol:water (1:1). |
70–90 | 1 | PK-NET221X | |
| Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl-3H]- Packaged in 10 mM tricine (pH 7.6). |
70–90 | 2.5 | PK-NET221A | |
| Deoxythymidine 5’-triphosphate, tetrasodium salt, [methyl, 1’,2’-3H] Packaged in 10 mM tricine (pH 7.6). |
90–120 | 2.5 | PK-NET520A |
14C 標定產品
14C-Labeled Amino Acids
| Product | Molecular Formula & Labeling Position(s) | Specific Acticity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
|---|---|---|---|---|
| Alanine, L-[14C(U)]- | CH3CH(NH2)CO2H | >150 | 0.1 | PK-NEC266E |
| Arginine L-[14C(U)]- | H2NC(NH)NH(CH2)3CH(NH2)CO2H.HCl | >300 | 0.1 | PK-NEC267E |
| Cystine L-[14C(U)]- | (HO2CCH(NH2)CH2S)2 | >250 | 0.02 | PK-NEC465 |
| Glutamic Acid, L-[14C(U)]- | HO2C(CH2)2CH(NH2)CO2H | >250 | 0.1 | PK-NEC290E |
| Glycine, [14C(U)]- | H2NCH2CO2H | >100 | 0.1 | PK-NEC276E |
| Isoleucine, L-[14C(U)]- | CH3CH2CH(CH3)CH(NH2)CO2H | >300 | 0.05 | PK-NEC278E |
| Leucine, L-[14C(U)]- | (CH3)2CHCH2CH(NH2)CO2H | >300 | 0.1 | PK-NEC279E |
| Lysine, L-[14C(U)]- | H2NCH2(CH2)3CH(NH2)CO2H.HCl | >300 | 0.1 | PK-NEC280E |
| Phenylalanine, L-[14C(U)]- | C6H5CH2CH(NH2)CO2H | >450 | 0.1 | PK-NEC284E |
| Proline, L-[14C(U)]- | HN2H2CH2CH2CHCO2H | >250 | 0.1 | PK-NEC285E |
| Serine, L-[14C(U)]- | HOCH2CH(NH2)CO2H | >150 | 0.1 | PK-NEC286E |
| Serine, L-[3- 14C]- | HOCH2(NH2)CO2H | 50-62 | 0.05 | PK-NEC827 |
| Tyrosine L-[14C(U)]- | HOPHCH2CH(NH2)CO2H | >450 | 0.05 | PK-NEC289E |
| L-Amino acid mixture, [14C(U)]- A mixture of L-Ala, L-Arg, L-Asp, L-Glu, Gly, L-His, L-Ile, L-Leu, L-Lys, L-Phe, L-Pro, L-Ser, L-Thr, L-Tyr and L-Val |
N/A | N/A | 0.1 | PK-NEC445E |
14C-Labeled Thymidines
| Application | Product | Specific Acticity [Ci/mmol] |
Activity Conc. [mCi/ml] |
Cat. No. |
|---|---|---|---|---|
| To study DNA proliferation rates | Thymidine, [methyl-14C]- Steri-packaged in an aqueous solution. Not for human use. |
40–60 | 0.1 | PK-NEC568 |
| Thymidine, [methyl-14C]- Steri-packaged in aquesous solution Not for human use |
50-62 | 1 | PK-NEC568D | |
| To study total nucleic acid proliferation rates | Thymidine, [2-14C]- Steri-packaged in an aqueous solution. Not for human use. |
>50 | 0.1 | PK-NEC156 |
放射性核種
| Radionuclide | Packaging & Form | Specific Activity | Fresh Lot Availability | Cat. No. |
|---|---|---|---|---|
| Calcium-45 Symbol: 45Ca Half Life: 163 d Radiation Type: beta |
As calcium chloride in aqueous solution | >10 Ci/g | Every 4 weeks | PK-NEZ013 |
| Chromium-51 Symbol: 51Cr Half Life: 27.7 d Radiation Type: gamma |
As chromium chloride in 0.5 M HCl. |
>50 Ci/g | Every 4 weeks | PK-NEZ020 |
| As sodium chromate in normal saline (pH 8–10). Steri-packaged; not for human use. 5mci/ml | 400–1200 Ci/g | Every 4 weeks | PK-NEZ030 | |
| As sodium chromate in normal saline (pH 8–10). Steri-packaged; not for human use. 1mci/ml | 400–1200 Ci/g | Every 4 weeks | PK-NEZ030S | |
| As EDTA complex in 0.005 M EDTA (pH 7.0) | >50 Ci/g | Every 4 weeks | PK-NEZ147 | |
| Cobalt-57 Symbol: 57Co Half Life: 271 d Radiation Type: gamma |
Packaged in 0.1M HCL | carrier free | Routinrly available | PK-NEZ022 |
| Indium-111 Symbol: 111In Half Life: 2.83 d Radiation Types: x-ray, gamma |
As indium chloride in 0.05 M HCl. Not for human use. |
380–415 Ci/mg | Every Friday | PK-NEZ304 PK-NEZ304A PK-NEZ304B PK-NEZ304C |
